HEALTH● LOWJul 21 · Jul 21, 2026, 6:09 AM
CDSCO clears recombinant live attenuated dengue vaccine for ages 4 to 60 years
The Hindu
‘The approval has been granted after a comprehensive scientific evaluation of the vaccine’s quality, safety and efficacy,’ said the Union Health Ministry
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Health
HEALTH39m agoAs diseases loom , CDC response to measles deaths stirs fears about agency reliabilitykpcw.org · United StatesHEALTH39m agoSwooping bats , attacking beavers and wild raccoons : US rabies cases rose 17 percent this summerindependent.co.uk · United KingdomHEALTH1h agoHealth unit confirms first case of influenza seasonthepeterboroughexaminer.com · CanadaHEALTH1h agoCMC organises annual conference on brachytherapyThe Hindu